ASTIM ALLERJI IMMUNOLOJI
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherBILIMSEL TIP YAYINEVI
- LanguageEnglish
- FrequencyQuarterly
- LanguageEnglish
- FrequencyQuarterly
- Publication Start Year2010
- Website URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has ASTIM ALLERJI IMMUNOLOJI been publishing? 
The ASTIM ALLERJI IMMUNOLOJI has been publishing since 2010 till date.
How frequently is the ASTIM ALLERJI IMMUNOLOJI published?
ASTIM ALLERJI IMMUNOLOJI is published Quarterly.
Who is the publisher of ASTIM ALLERJI IMMUNOLOJI?
The publisher of ASTIM ALLERJI IMMUNOLOJI is BILIMSEL TIP YAYINEVI.
How can I view the journal metrics of ASTIM ALLERJI IMMUNOLOJI on editage?
For the ASTIM ALLERJI IMMUNOLOJI metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of ASTIM ALLERJI IMMUNOLOJI?
The eISSN number is 1308-9234 and pISSN number is 1308-9234 for ASTIM ALLERJI IMMUNOLOJI.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Common variable immunodeficiency, Food allergy, Anaphylaxis, Atopic dermatitis, Omalizumab, Chronic urticaria.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.